Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC
Clinical trial NCT07398937 · RECRUITING
Trial details
- NCT number
- NCT07398937
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-05
- Primary completion
- 2027-12-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.